Vision Quest 2013
Listen to informative lectures and discussions from Vision Quest 2013!
Ride for Sight
Join us for Canada's biggest and longest-running motorcycle charity ride. The best party of the summer!
Cycle for Sight
Join us for Cycle for Sight and see what you're made of!
Share the laughter. See the hope. Join us for the 2013 Comic Vision tour & Comic Vision: Last Call - the most fun-filled, casual fundraising events of the season!
News & Events
Vision Researcher talks about his own Experiences with Retinitis Pigmentosa
Nov 20, 2013 - Stuart Lithwick is a PhD candidate training in Dr. Valerie Wallace's research laboratory at Toronto Western Hospital. These scientists are working towards a way to restore vision to those of have lost all or most of their sight.
Stuart is also living with retinitis pigmentosa. On CBC Metro Morning, he talked about what being part of this research means to him and how he was inspired to return to a research career at Vision Quest in 2010.
New Wet AMD Drug, Eylea, Approved in Canada
November 12, 2013 - Another treatment option for people with wet age-related macular degeneration (AMD) has been approved and will become available in the new year.
Foundation Fighting Blindness Patient Registry Now Enrolling in Halifax
Oct 22, 2013 - The Foundation Fighting Blindness Patient Registry is a tool to help connect people living with inherited eye diseases (such as retinitis pigmentosa or Stargardt disease) to scientists studying these conditions. By participating in the Registry, you can help create a database of information so that scientists can better study and understand these conditions and so they can find participants for clinical trials. IWK Health Centre in Halifax has just joined the list of centres where you can enrol in the Registry. The link below offers more information about the registry including contact information for the Halifax site.
International Society of Genetic Eye Diseases and Retinoblastoma Conference Report
October 22, 2013 - This conference is an opportunity for scientists and health professionals from around the world to come together and find out more about the latest in vision research. Joanne Sutherland, ocular genetic consellor at the Hospital for Sick Children attended, and shares the highlights!
Ocular Gene Therapy Centre Established at the University of Alberta
Oct 9, 2013 - A multi-million dollar investment by the Alberta government will create a unique centre for testing gene therapies for inherited eye disease.
Drug for Dry AMD Looks Promising in Early Clinical Trials
Sept 16, 2013 - A new drug, now completely phase II clinical trials, may become the first drug treatment for dry age-related macular degeneration. These early trials suggest that the drug will be usefl for only some people with dry AMD. Testing to identify the people that will benefit most will likely become part of AMD treatment.
2012 Annual Report
Accountable to You
Our 2012 Annual Report is now available. It’s just one more way we’re accountable to you, our community of dedicated donors, sponsors, volunteers, event participants, researchers and individuals and families living with vision loss.
In it you’ll read about the hope your support provides to just three of the 1 million Canadian families living with vision loss. You’ll also find updates from our signature fundraising events: Ride for Sight, Comic Vision, and Cycle for Sight, as well as information on our Vision Quest educational series, and, of course, our audited financial statements.
Your donations supported a total of 23 ongoing research projects across the country in 2012 – over $1.8 million in new Canadian vision research. And thanks to your generosity, Foundation research funding increased 35% in 2012 over 2011.
Our 2012 Annual Report is also an expression of our deep gratitude for your commitment to vision research and our mission to understand, preserve and restore sight.
Transplant Retinal Cells Gathered from a Person's Own Body to Begin Testing in Japan
August 26, 2013 - This clinical trial will test a new approach to stem cell therapy for people with age-related macular degeneration. If successful, it will encourage the development of sight-restoring therapies for many types of retinal disease utilizing this approach.
Vision Quest 2013 is coming to a city near you!
Toronto (AMD only) - September 17
London - September 28
Vancouver - November 2
Ottawa - November 9